GREENLAND MINES LTD Shares Outstanding (Cover Page)
GREENLAND MINES LTD (GRML) had Shares Outstanding (Cover Page) of 158.85 million shares as of 2026-08-17, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-17
- 2026-08-17: Entity Common Stock, Shares Outstanding 158.85M shares.
- 2026-05-20: Entity Common Stock, Shares Outstanding 121.24M shares.
- 2026-03-31: Entity Common Stock, Shares Outstanding 121.24M shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 72.54M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-17 | 158.85M shares 10-Q · filed 2026-08-17 |
| 2026-05-20 | 121.24M shares 10-Q/A · filed 2026-08-14 |
| 2026-03-31 | 121.24M shares 10-K/A · filed 2026-08-14 |
| 2025-11-13 | 72.54M shares 10-Q · filed 2025-11-13 |
| 2025-08-15 | 61.37M shares 10-Q · filed 2025-08-18 |
| 2025-05-14 | 32.49M shares 10-Q · filed 2025-05-15 |
| 2025-03-31 | 28.51M shares 10-K · filed 2025-03-31 |
| 2024-11-19 | 21.26M shares 10-Q · filed 2024-11-19 |
| 2024-08-16 | 17.23M shares 10-Q · filed 2024-08-19 |
| 2024-05-22 | 5.17M shares 10-Q · filed 2024-05-23 |
| 2024-04-16 | 1.76M shares 10-K · filed 2024-04-17 |
| 2023-11-15 | 8.80M shares 10-Q · filed 2023-11-17 |
| 2023-08-21 | 8.80M shares 10-Q · filed 2023-08-21 |
| 2023-05-19 | 8.80M shares 10-Q · filed 2023-05-24 |
| 2023-04-07 | 8.80M shares 10-K/A · filed 2023-10-18 |
| 2022-11-14 | 14.90M shares 10-Q · filed 2022-11-14 |
| 2022-08-10 | 14.90M shares 10-Q · filed 2022-08-15 |
| 2022-05-12 | 14.90M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |